Scilex Holding Company Announces That The U.S. Bankruptcy Court Has Extended The Lockup Period On Shares Of Scilex Dividend Stock Previously Distributed By Sorrento To Its Stockholders As A Dividend To January 31, 2025
Scilex Holding Company Announces That The U.S. Bankruptcy Court Has Extended The Lockup Period On Shares Of Scilex Dividend Stock Previously Distributed By Sorrento To Its Stockholders As A Dividend To January 31, 2025
- US Bankruptcy Court for the Southern District of Texas issued an order to extend the lock-up period on the Scilex Dividend Stock, previously distributed by Sorrento, to January 31, 2025.
- Accordingly, any shares of the Dividend Stock (including any such shares held by brokerage firms) may not be sold, transferred or otherwise disposed of.
- Scilex's transfer agent, Continental Stock Transfer & Trust Company, has been notified of the lock-up extension to January 31, 2025.
- 德克萨斯州南部的美国破产法院发布了一项命令，将Scilex分红股票的锁定期延长至2025年1月31日，该股票前由Sorrento分配。
- 因此，任何Scilex分红股票的股份（包括券商持有的股份）均不得出售、转让或以其他方式处置。
- Scilex的转让代理机构，大陆股份转让与信托公司，已经被告知将锁定期延长至2025年1月31日。
PALO ALTO, Calif., Sept. 26, 2024 (GLOBE NEWSWIRE) -- Scilex Holding Company (NASDAQ:SCLX, "Scilex"))))), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain, today announced that the U.S. Bankruptcy Court for the Southern District of Texas (the "Court") has extended the expiration of the restrictions on transfer of the shares of common stock of Scilex that were previously distributed by Sorrento Therapeutics, Inc. (OTC:SRNEQ, "Sorrento"))))), Scilex's former controlling stockholder, to Sorrento's stockholders as a dividend on January 19, 2023 (the "Dividend Stock"). Such lock-up period was previously set to expire on the earlier of (i) September 30, 2024 or (ii) the date on which Sorrento and its Official Committee of Unsecured Creditors agreed in writing or on the record in Sorrento's chapter 11 cases certain claims that may be asserted in potential litigation to avoid Sorrento's distribution of Dividend Stock and to recover such Dividend Stock, should not be pursued, or on such date that the Court deems just and proper. On September 25, 2024, the Court approved a motion to extend the lock-up period on the Dividend Stock to January 31, 2025.
加利福尼亚州帕洛阿尔托，2024年9月26日（环球新闻社）--Scilex控股公司（纳斯达克股票代码：SCLX，"Scilex"）是一家专注于收购、开发和商业化非阿片类疼痛管理产品的创新营业收入公司，用于治疗急性和慢性疼痛，今日宣布，美国德克萨斯州南部破产法院（"法院"）已将扩展Scilex普通股转让限制的有效期延长至解除股票分红的限制。Scilex之前由Sorrento Therapeutics, Inc.（场外交易：SRNEQ，"Sorrento"）作为Scilex前控股股东向Sorrento的股东于2023年1月19日分发的普通股的分红（"分红股票"），此类锁定期之前被设定为在2024年9月30日或Sorrento及其无抵押债权人官方委员会在Sorrento第11章破产案件中书面同意或记录的早于的日期结束，以避免Sorrento分配分红股票的潜在诉讼索赔，并收回该股票，或法院认为适当的日期结束。 2024年9月25日，法院批准了延长分红股票锁定期至2025年1月31日的动议。
